| pubmed-article:17878480 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17878480 | lifeskim:mentions | umls-concept:C1516213 | lld:lifeskim |
| pubmed-article:17878480 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:17878480 | lifeskim:mentions | umls-concept:C0684249 | lld:lifeskim |
| pubmed-article:17878480 | lifeskim:mentions | umls-concept:C1522449 | lld:lifeskim |
| pubmed-article:17878480 | lifeskim:mentions | umls-concept:C1521808 | lld:lifeskim |
| pubmed-article:17878480 | lifeskim:mentions | umls-concept:C1513884 | lld:lifeskim |
| pubmed-article:17878480 | lifeskim:mentions | umls-concept:C1521726 | lld:lifeskim |
| pubmed-article:17878480 | lifeskim:mentions | umls-concept:C0282460 | lld:lifeskim |
| pubmed-article:17878480 | lifeskim:mentions | umls-concept:C1696465 | lld:lifeskim |
| pubmed-article:17878480 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
| pubmed-article:17878480 | lifeskim:mentions | umls-concept:C1628324 | lld:lifeskim |
| pubmed-article:17878480 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:17878480 | lifeskim:mentions | umls-concept:C0205197 | lld:lifeskim |
| pubmed-article:17878480 | lifeskim:mentions | umls-concept:C1704648 | lld:lifeskim |
| pubmed-article:17878480 | pubmed:issue | 27 | lld:pubmed |
| pubmed-article:17878480 | pubmed:dateCreated | 2007-9-19 | lld:pubmed |
| pubmed-article:17878480 | pubmed:abstractText | This double-blind randomized phase II trial examined whether vandetanib, an inhibitor of vascular endothelial and epidermal growth factor receptors, could prolong progression-free survival in responding patients with small-cell lung cancer. | lld:pubmed |
| pubmed-article:17878480 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17878480 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17878480 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17878480 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17878480 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17878480 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17878480 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17878480 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17878480 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17878480 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:17878480 | pubmed:issn | 1527-7755 | lld:pubmed |
| pubmed-article:17878480 | pubmed:author | pubmed-author:MeiS SSS | lld:pubmed |
| pubmed-article:17878480 | pubmed:author | pubmed-author:WhiteheadMarl... | lld:pubmed |
| pubmed-article:17878480 | pubmed:author | pubmed-author:SeymourLesley... | lld:pubmed |
| pubmed-article:17878480 | pubmed:author | pubmed-author:EllisPeterP | lld:pubmed |
| pubmed-article:17878480 | pubmed:author | pubmed-author:DingKeyueK | lld:pubmed |
| pubmed-article:17878480 | pubmed:author | pubmed-author:LeeChristophe... | lld:pubmed |
| pubmed-article:17878480 | pubmed:author | pubmed-author:SmylieMichael... | lld:pubmed |
| pubmed-article:17878480 | pubmed:author | pubmed-author:FindlayBrianB | lld:pubmed |
| pubmed-article:17878480 | pubmed:author | pubmed-author:ArnoldAndrew... | lld:pubmed |
| pubmed-article:17878480 | pubmed:author | pubmed-author:GossGlenwoodG | lld:pubmed |
| pubmed-article:17878480 | pubmed:author | pubmed-author:GreggRichardR | lld:pubmed |
| pubmed-article:17878480 | pubmed:author | pubmed-author:ButtsCharlesC | lld:pubmed |
| pubmed-article:17878480 | pubmed:author | pubmed-author:LangmuirPeter... | lld:pubmed |
| pubmed-article:17878480 | pubmed:author | pubmed-author:ShepherdFranc... | lld:pubmed |
| pubmed-article:17878480 | pubmed:author | pubmed-author:National... | lld:pubmed |
| pubmed-article:17878480 | pubmed:author | pubmed-author:DjurfeldtMari... | lld:pubmed |
| pubmed-article:17878480 | pubmed:author | pubmed-author:ChanAdrienA | lld:pubmed |
| pubmed-article:17878480 | pubmed:author | pubmed-author:MeharchandJac... | lld:pubmed |
| pubmed-article:17878480 | pubmed:author | pubmed-author:AlamYasminY | lld:pubmed |
| pubmed-article:17878480 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:17878480 | pubmed:day | 20 | lld:pubmed |
| pubmed-article:17878480 | pubmed:volume | 25 | lld:pubmed |
| pubmed-article:17878480 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17878480 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17878480 | pubmed:pagination | 4278-84 | lld:pubmed |
| pubmed-article:17878480 | pubmed:dateRevised | 2007-12-31 | lld:pubmed |
| pubmed-article:17878480 | pubmed:meshHeading | pubmed-meshheading:17878480... | lld:pubmed |
| pubmed-article:17878480 | pubmed:meshHeading | pubmed-meshheading:17878480... | lld:pubmed |
| pubmed-article:17878480 | pubmed:meshHeading | pubmed-meshheading:17878480... | lld:pubmed |
| pubmed-article:17878480 | pubmed:meshHeading | pubmed-meshheading:17878480... | lld:pubmed |
| pubmed-article:17878480 | pubmed:meshHeading | pubmed-meshheading:17878480... | lld:pubmed |
| pubmed-article:17878480 | pubmed:meshHeading | pubmed-meshheading:17878480... | lld:pubmed |
| pubmed-article:17878480 | pubmed:meshHeading | pubmed-meshheading:17878480... | lld:pubmed |
| pubmed-article:17878480 | pubmed:meshHeading | pubmed-meshheading:17878480... | lld:pubmed |
| pubmed-article:17878480 | pubmed:meshHeading | pubmed-meshheading:17878480... | lld:pubmed |
| pubmed-article:17878480 | pubmed:meshHeading | pubmed-meshheading:17878480... | lld:pubmed |
| pubmed-article:17878480 | pubmed:meshHeading | pubmed-meshheading:17878480... | lld:pubmed |
| pubmed-article:17878480 | pubmed:meshHeading | pubmed-meshheading:17878480... | lld:pubmed |
| pubmed-article:17878480 | pubmed:meshHeading | pubmed-meshheading:17878480... | lld:pubmed |
| pubmed-article:17878480 | pubmed:meshHeading | pubmed-meshheading:17878480... | lld:pubmed |
| pubmed-article:17878480 | pubmed:meshHeading | pubmed-meshheading:17878480... | lld:pubmed |
| pubmed-article:17878480 | pubmed:meshHeading | pubmed-meshheading:17878480... | lld:pubmed |
| pubmed-article:17878480 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17878480 | pubmed:articleTitle | Phase II study of vandetanib or placebo in small-cell lung cancer patients after complete or partial response to induction chemotherapy with or without radiation therapy: National Cancer Institute of Canada Clinical Trials Group Study BR.20. | lld:pubmed |
| pubmed-article:17878480 | pubmed:affiliation | National Cancer Institute of Canada-Clinical Trials Group, Kingston, Ontario, Canada. | lld:pubmed |
| pubmed-article:17878480 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17878480 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:17878480 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:17878480 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17878480 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17878480 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17878480 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17878480 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17878480 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17878480 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17878480 | lld:pubmed |
